Results 201 to 210 of about 892,868 (364)
CAR-T cell therapy: A new dawn in the treatment of autoimmune disease. [PDF]
Yan S, Zhu X, Xiao Y.
europepmc +1 more source
A Bite of B Cells: The Potential Role of Bispecific T Cell Engager Therapy (
Jie‐Fu Zheng +3 more
openalex +1 more source
The coexistence of autoimmune rheumatic diseases and thymomas [PDF]
Ying Jiang +3 more
openalex +1 more source
Objective This research article aims to describe the prevalence, associations and health‐related quality‐of‐life (HRQoL) impact of mucocutaneous features of SLE. Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analysed (2013‐2021). Mucocutaneous activity (MC‐A) items were rash, alopecia and mucosal ulcers; defined by the SLEDAI‐2K ...
Amanda M Saracino +42 more
wiley +1 more source
Th17 cell pathogenicity in autoimmune disease. [PDF]
Park E, Ciofani M.
europepmc +1 more source
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Clinical characterization and targeted genetic mutation profiling of autoimmune disease-associated B-cell lymphoma. [PDF]
Di H +7 more
europepmc +1 more source
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin +14 more
wiley +1 more source
Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease. [PDF]
Drweesh H +14 more
europepmc +1 more source

